Edition:
United States

People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

104.88USD
9 Dec 2016
Change (% chg)

$1.25 (+1.21%)
Prev Close
$103.63
Open
$104.47
Day's High
$107.56
Day's Low
$103.28
Volume
195,266
Avg. Vol
400,493
52-wk High
$139.79
52-wk Low
$82.06

Berkman, Charles 

Mr. Charles S. Berkman J.D., serves as Vice President, General Counsel, Secretary of Ligand Pharmaceuticals Incorporated since April 2007. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a BS in chemistry from the University of Texas and a JD from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD 426,474
Restricted Stock Awards, USD 512,641
Long-Term Incentive Plans, USD --
All Other, USD 523,337
Fiscal Year Total, USD 1,462,450

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 20,331 1,549,740.00
Name Fiscal Year Total

John Kozarich

303,029

Matthew Foehr

3,357,290

John Higgins

4,550,720

Matthew Korenberg

2,797,980

Charles Berkman

1,462,450

Jason Aryeh

285,529
As Of  30 Dec 2015